Longeveron (LGVN) Deferred Taxes (2020 - 2023)
Longeveron's (LGVN) quarterly Deferred Taxes came in at -$1.3 million in Q2 2023, down 8886.67% year-on-year from $15341.4 in Q2 2022, and down 2596.0% quarter-over-quarter from -$50000.0 in Q1 2023.
Longeveron (LGVN) Deferred Taxes (2020 - 2023) Analysis & Trends
Longeveron's Deferred Taxes history runs 4 years deep, the most recent figure standing at -$1.3 million for Q2 2023.
- On a quarterly basis, Deferred Taxes fell 8886.67% year-over-year to -$1.3 million in Q2 2023; TTM through Dec 2023 was -$1.4 million, a N/A change from a year earlier, with the FY2023 full-year figure at -$1.4 million, down 355.37% from the prior year.
- Deferred Taxes fell to -$1.3 million in Q2 2023 per LGVN's latest filing, from -$50000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $339000.0 in Q2 2020 and bottomed at -$1.3 million in Q2 2023.
- The 4-year median for Deferred Taxes is -$5500.0 (2021), against an average of -$114583.3.
- Across the five-year window, Deferred Taxes surged 113.86% in 2021 and plunged 8886.67% in 2023, its largest moves.
- Year by year, Deferred Taxes stood at $232000.0 in 2020, then slumped by 98.28% to $4000.0 in 2021, then plunged by 475.0% to -$15000.0 in 2022, then plunged by 8886.67% to -$1.3 million in 2023.
- Per Business Quant, the three latest LGVN Deferred Taxes figures stand at -$1.3 million (Q2 2023), -$50000.0 (Q1 2023), and -$15000.0 (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Longeveron | 3.97 Mn | -11.79 Mn | 264,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1.35 Mn |
| Mar 31, 2023 | -50,000.00 |
| Jun 30, 2022 | -15,000.00 |
| Mar 31, 2022 | -306,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 28,000.00 |
| Jun 30, 2021 | 155,000.00 |
| Mar 31, 2021 | -375,000.00 |
| Dec 31, 2020 | 232,000.00 |
| Sep 30, 2020 | -202,000.00 |
| Jun 30, 2020 | 339,000.00 |
| Mar 31, 2020 | 163,000.00 |